Jade Biosciences
Formerly Aerovate Therapeutics, a Raven-incubated company

Aerovate was incubated by Raven and is now Jade Biosciences. Jade Biosciences develops autoimmune therapies. Lead candidate JADE101 inhibits APRIL to treat IgAN.

Domain
Healthcare
Status
IPO’d/​Acquired
IPO Date
2021
Stage of Initial Investment
NewCo
Initial Investment Year
2018
Jade Hover Image